13 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Common mechanisms and pathways in Stroke and Alzheimer's disease. (CoSTREAM)
Date du début: 1 déc. 2015, Date de fin: 30 nov. 2020,
Common mechanisms and pathways in Stroke and Alzheimer's disease.It has long been recognized that stroke and (Alzheimer’s Disease) AD often co-occur and have an overlapping pathogenesis. As such, these two diseases are not considered fellow travelers, but rather partners in crime. This multidisciplinary consortium includes epidemiologists, geneticists, radiologists, neurologists with a longstandin ...
Voir le projet
11
Participants partenaires
TERMINÉ
Smart optical and ultrasound diagnostics of breast cancer (SOLUS)
Date du début: 1 déc. 2016, Date de fin: 30 nov. 2020,
SOLUS is a trans-disciplinary 48-month project bringing together 9 partners: industries (4), academic and clinical institutions from 5 countries (engineers, physicists and radiologists) representing cutting-edge expertise in their fields, to develop an innovative non-invasive, point-of-care, low-cost, easy-to-operate, multi-modal imaging system (diffuse optics and ultrasounds/shear wave elastograp ...
Voir le projet
10
Participants partenaires
TERMINÉ
Laser and Ultrasound Co-Analyzer for thyroid nodules (LUCA)
Date du début: 1 févr. 2016, Date de fin: 31 janv. 2020,
This is a trans-disciplinary project that joins endocrinologists (“end-users”), radiologists (“end-users”), physicists who are experts in medical photonics, engineers who are experts in photonics and ultrasonics and the industry to work towards a concentrated goal - to produce a novel, point-of-care, low-cost, screening device that combines two photonics systems (near-infrared diffuse correlation ...
Voir le projet
8
Participants partenaires
TERMINÉ
Digital Hybrid Breast PET/MRI for Enhanced Diagnosis of Breast Cancer (HYPMED)
Date du début: 1 janv. 2016, Date de fin: 31 déc. 2019,
Breast cancer represents a leading cause of cancer death in women and a major socio-economic issue. With currently available methods, early diagnosis frequently fails. Moreover, beyond mere detection, there is an ever-increasing need for improved non-invasive characterisation of cancer. Targeted therapies require an in-depth analysis of cancer to select and guide appropriate treatment. Both, PET a ...
Voir le projet
10
Participants partenaires
TERMINÉ
GlucoCEST Imaging of Neoplastic Tumours (GLINT)
Date du début: 1 janv. 2016, Date de fin: 31 déc. 2019,
Cancer is one of the most devastating diseases the world is currently facing, accounting for 7.6 million deaths in 2008 (WHO). Cancer is usually detected through advanced medical imaging. Early detection is very important as it increases the chances of survival and the potential for full recovery. Further, The high level of sophistication in treating cancer has led to a new unsolved problem, the d ...
Voir le projet
8
Participants partenaires
TERMINÉ
EU eHealth Interoperability Conformity Assessment Scheme (EURO-CAS)
Date du début: 1 déc. 2016, Date de fin: 30 nov. 2018,
EURO-CAS, European eHealth Interoperability Conformity Assessment Scheme aims at maintaining and developing the adoption and take-up of testing the interoperability of ICT solutions against identified eHealth standards and profiles defined in the eHealth European Interoperability Framework (eEIF). The key deliverable is a sustainable Conformity Assessment Scheme (CAS) for Europe. Based on recommen ...
Voir le projet
16
Participants partenaires
TERMINÉ
Closed-loop Molecular Environment for Minimally Invasive Treatment of Patients with metastatic Gastrointestinal Stromal Tumours (MITIGATE)
Date du début: 1 oct. 2013, Date de fin: 30 sept. 2017,
Gastrointestinal stromal tumours (GIST) are a rare disease that metastasises in up to 85% of patients with subsequent median progression-free survival (PFS) of only around 30 months. Tumours are characterised by activating mutations in the KIT or the PDGFRA gene and therefore treatment is mainly based on tyrosine kinase inhibitors designed to block these mutated receptors. However, drug resistance ...
Voir le projet
10
Participants partenaires
TERMINÉ
VPH Dementia Research Enabled by IT (VPH-DARE@IT)
Date du début: 1 avr. 2013, Date de fin: 31 mars 2017,
The DementiA Research Enabled by IT project responds to the European Parliament's 2011 resolution for a European Initiative on Alzheimer's disease and other dementias, and the EU Year of the Brain 2014 Initiative. It delivers the first patient-specific predictive models for early differential diagnosis of dementias and their evolution. Its mechanistic/phenomenological models of the ageing brain ac ...
Voir le projet
22
Participants partenaires
TERMINÉ
Virtual Physiological Human: Personalized Predictive Breast Cancer Therapy Through Integrated Tissue Micro-Structure Modeling (VPH-PRISM)
Date du début: 1 mars 2013, Date de fin: 29 févr. 2016,
... EU funded project consists of 9 project partners with leading expertise in the field of pathological and radiological imaging, image processing as well as biophysical and statistical modelling, with EIBIR as the coordinating partner. The 3-year project offical start date is 1 March 2013 and is supported by the European Commission with a financial contribution of €3.7m.
Voir le projet
9
Participants partenaires
TERMINÉ
Euro-BioImaging - Research infrastructure for imaging technologies in biological and biomedical sciences (Euro-BioImaging)
Date du début: 1 déc. 2010, Date de fin: 31 mai 2014,
Euro-BioImaging brings together imaging technologies stretching from basic biological imaging with advanced light microscopy, in vivo molecular imaging of single cells to animal models up to the clinical and epidemiological level of medical imaging of humans and populations. Euro-BioImaging, in close consultation with its stakeholders, will address the imaging requirements of both biological and m ...
Voir le projet
44
Participants partenaires
TERMINÉ
European Network for Cell Imaging and Tracking Expertise (ENCITE)
Date du début: 1 juin 2008, Date de fin: 30 nov. 2012,
"Cell therapy can be defined as the transplantation of living cells for the treatment of medical disorders. Three different principles underlie the increasing interest in cell therapy. 1. Transplanted cells used as an “active drug” 2. Transplanted cells used to replace damaged and degenerated tissue. 3. Cells used as a drug delivery vehicle. Promising results have been obtained in pre-clinical and ...
Voir le projet
30
Participants partenaires
TERMINÉ
Highly Accurate Breast Cancer Diagnosis through Integration of Biological Knowledge, Novel Imaging Modalities, and Modelling (HAMAM)
Date du début: 1 sept. 2008, Date de fin: 29 févr. 2012,
Despite tremendous advances in modern imaging technology, both early detection and accurate diagnosis of breast cancer are still unresolved challenges. Today, a variety of imaging modalities and image-guided biopsy procedures exist to identify and characterize morphology and function of suspicious breast tissue. However, a clinically feasible solution for breast imaging, which is both highly sensi ...
Voir le projet
10
Participants partenaires
TERMINÉ
Dosimetry and Health Effects of Diagnostic Applications of Radiopharmaceuticals with particular emphasis on the use in children and adolescents (PEDDOSE.NET)
Date du début: 1 avr. 2010, Date de fin: 31 janv. 2012,
...ximum activities with particular emphasis on paediatric nuclear medicine will be developed. The dissemination of results will be coordinated by the European Institute for Biomedical Imaging Research (EIBIR) and undertaken with the help of the radiation protection authorities in individual member states and the European Association of Nuclear Medicine (EANM)."
Voir le projet